Search

Binge Eating Disorder (BED) is characterized by excessive uncontrolled consumption of food, generating physical and emotional discomfort. The research focuses on investigating executive functions (EFs) in individuals with BED, focusing on Inhibitory Control (IC), with the ultimate objective of understanding the role of IC in irregular eating behavior. The research methodology was a systematic bibliographic review in the main databases and repositories using the keywords "binge eating", "eating disorder neuropsychology", "psychology", "executive functions" and "inhibitory control". The inclusion criteria were: a) empirical and review articles; b) approach to EFs and BED; c) researches in Portuguese and English. The results found indicated a scarcity of Brazilian studies on the topic, with only two of the 21 studies selected. The analysis of the main findings highlights the interconnection between BED and executive dysfunctions, especially IC, with possible structural changes in the brain reward system. In conclusion, the study evidenced the relevance of therapeutic interventions focused on IC training, in addition to exposing the lack of research in a country where eating disorders affect a large portion of the population. Furthermore, in future studies it is suggested to use approaches with greater standardization, objective assessment methods and consideration of environmental factors to advance the understanding of the role of IC in BED. [ABSTRACT FROM AUTHOR]

Proton pump inhibitors (PPIs) are the most potent drugs to inhibit gastric acid secretion, being used in the treatment of most inflammatory conditions of the gastric mucosa. They are among the most prescribed and overprescribed medications worldwide; for example, in the United States, according to the National Health and Nutrition Examination Survey, they almost doubled their use in adults aged 40 years and older from 4.9 % to 8.3 % between 1999 and 2012. Although they are generally considered well tolerated, some epidemiological studies extracting information from large databases have reported a number of adverse effects associated with their prolonged use, including cognitive impairment, chronic kidney disease, myocardial infarction, stroke, bone fractures and even death, among others. The objective was to conduct a narrative review of the literature on the effects of chronic use of PPIs on cognitive impairment in older adults. Articles were reviewed based on a search in the PubMed, Scopus and SciELO databases using both English and Spanish keywords and related MeSH/DeCS terms. Neurological side effects induced by chronic PPI use may be indirectly related to secondary systemic disorders (magnesium and vitamin B12 deficiency) or to direct effects on neuronal functioning after passing through the blood-brain barrier. Although several neurobiological mechanisms by which PPIs could favor the development of dementia--which involve Tau protein function, beta-amyloid [ßA] accumulation and cobalamin deficiency, among others--have been described, most of the available clinical evidence has not shown a significant association between PPI use and the risk of dementia or cognitive impairment. To establish the adverse clinical effects of chronic PPI use more clearly, especially on brain functioning, well-designed cohort studies with large sample sizes and long follow-up periods, with a reliable method to adjust for standardized confounders, as well as subgroup analyses are needed. [ABSTRACT FROM AUTHOR]

Background: COVID-19 is associated with multiple complications, in addition to those produced at the pulmonary level. Post-COVID-19 cognitive deficits have been detected in the cognitive domain of attention and executive functions, even 4 months after COVID-19. Objective: to determine the frequency of cognitive alterations in patients recovered from COVID-19. Material and methods: A cross-sectional, descriptive and analytical study was carried out. Records of patients in care after infection by SARS-CoV-2 were integrated, the Neuropsi test was applied. Descriptive statistics and association tests were used through the Chi square test, taking p < 0.05 as significant. Results: Data from 44 files were integrated. The median age, I place them in the sixth decade of life. There was a predominance of men (63.6%). The most frequent comorbidities were systemic arterial hypertension (50%) and diabetes mellitus (40.9%). Most of the patients were managed only at home (61.4%) with a moderate-severe COVID-19 picture (68.2%). The most affected dimensions of the Neuropsi test were attention and concentration (47.7%, mild alteration) and short-term memory (77.3%, mild alteration). Conclusions: Cognitive impairment in patients recovered from COVID-19 assessed through the Neuropsi test presented mild alterations in attention and concentration, as well as in short-term memory. These could affect functionality, quality of life and ability to perform work. [ABSTRACT FROM AUTHOR]

Background: Anti-LGI1 encephalitis is characterized by a pattern of inflammation that predominantly affects the limbic system It is part of the autoimmune encephalitis that attack neuronal surface antigens. It is characterized by the triad of subacute dementia, faciobrachial dystonic crises, and hyponatremia, presenting an excellent response to immunotherapy. The aim of this article is to describe the clinical evolution and functional outcome at 6 months of two patients with anti-LGI1 encephalitis using clinical cases. Clinical classes: Case 1: 62-year-old man with 8-week symptoms manifested by changes in mood, disorientation, and focal motor seizures. Case 2 A 72-year-old woman with a 5-month evolution of rapidly progressive dementia, hyponatremia and bitemporal hyperintensities on MRI. In both, due to clinical suspicion, acute dual immunotherapy with steroid and immunoglobulin was given with substantial improvement. Subsequently, the existence of anti-LGI1 antibodies in cerebrospinal fluid was confirmed. Although both patients received a dose of rituximab during their hospitalization, only the patient in the first case continued biannual doses of rituximab. The second patient was not initially considered to continue long-term immunomodulatory treatment and experienced a relapse. Conclusions: These clinical vignettes present the reader with the classic characteristics of this disease. This can facilitate its recognition and timely initiation of treatment, improving the functional prognosis of patients. [ABSTRACT FROM AUTHOR]

Copyright of Gerokomos is the property of Indemm Farma SL and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Background: With the increase in life expectancy, conditions related to older age have increased in incidence, one of these pathologies is Cognitive Impairment (CI), which has a prevalence of up to 28%, conditions that increase the presence of CI are known. However, there is controversy about the factors that increase the risk of CI. Objective: To determine the factors associated with cognitive impairment in older adults. Material and methods: We conducted a cross-sectional, analytical, observational, retroprolective study that included adults =65 years of age, with no history of cerebral vascular event, cranioencephalic trauma. Demographic factors were analyzed, CI was assessed with the Mini Mental State Examination test. Results: 420 older adults were included, 61% were women, 32.6% with age >75 years, 84.5% with schooling <9 years, in the multiple logistic regression the following were independent factors for the presence of mild CI: dependence on basic activities of daily living (ADLs) with OR 5.88, absence of cognitive stimulation RM 4.50, age >75 years OR 2.92, polypharmacy OR 2.16, uncontrolled blood pressure OR 1.92. Conclusion: ADLs dependence, absence of cognitive stimulation, age >75 years, polypharmacy and uncontrolled blood pressure are risk factors associated with CI in older adults. [ABSTRACT FROM AUTHOR]

Introduction: Age is the most important risk factor associated with cognitive deterioration. In this regard, loss of memory is a frequent and growing reason for attention in medical consultations of primary care. However, cognitive dysfunction in the elderly is one of the affections that usually go without an opportune diagnosis. Objective: To determine the prevalence of the amnestic mild cognitive impairment in elderly of a health area. Methods: An observational, descriptive and cross-sectional study of 203 elderly, belonging to the health area of Ramón López Peña Teaching Polyclinic was carried out in Santiago de Cuba, from June to December, 2022. To diagnose the patients with light cognitive dysfunction the Petersen approaches were used. Results: It was found that 36.9% of the elderly presented amnestic mild cognitive impairment, with a prevalence of male sex (43.6%) and the primary school level (50.0%), followed by the middle level (40.3%). Conclusions: Amnestic mild cognitive impairment prevailed in more than a third of the studied sample; frequency that increased according to the age. Likewise, a higher incidence of male sex and the elderly with concluded primary and middle schooling was detected. [ABSTRACT FROM AUTHOR]

Copyright of INSPILIP. Revista Ecuatoriana de Ciencia, Tecnología e Innovacion en Salud Pública is the property of Instituto Nacional de Investigacion en Salud Publica (INSPI) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Acta Médica Peruana is the property of Colegio Medico del Peru and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Background: The resident doctor plays an important role in people›s health care. Objective: To compare the cognition of medical residents with/without anxiety in a specialist training hospital. Material and methods: Comparative, prospective, crosssectional study. Medical residents of any grade and specialty were included, who signed informed consent. Those with a diagnosis of cognitive impairment were excluded, and who did not complete the tests were eliminated. AMASA test was applied to assess anxiety and NEUROPSI: Attention and memory test for cognitive characteristics. Mann-Whitney›s U and Spearman›s rho were used, p = 0.05 was considered significant. Results: 155 residents were evaluated, 55.5% men, mean age 32.4 years. Internal Medicine was the predominant specialty (25.2%). AMAS-A identified 94.19% residents with anxiety. NEUROPSI reported Attention and memory domain (38.7%) in normal classification, Memory (34.2%) in high normal, and Attention and executive functions (32.3%) in severe alteration as predominant assessments. Only Memory showed a significant difference between residents with and without anxiety (p = 0.015). Attention and executive functions-Physiological anxiety (r = -0.21, p=0.009) and Attention and memory-Social concern (r = -0.268, p = 0.001) correlations were significant. Conclusions: The percentage of anxiety and cognitive alterations in residents physicians is high. Anxiety decisively affects memory capacity in these medical doctors. [ABSTRACT FROM AUTHOR]

OBJECTIVE: To determine the prevalence of dementia syndrome and cognitive impairment in the elderly with hearing loss. MATERIALS AND METHODS: An observational, cross-sectional, descriptive study was performed in a third level hospital in Mexico City among adults ≥ 60 years with hearing loss. Participants were evaluated in the Otorhinolaryngology Service to identify the presence of dementia syndrome with the Phototest and cognitive impairment with the MoCA test. Statistical analysis was performed in SPSS v.26 with descriptive and inferential tests. RESULTS: A total of 47 older adults were included, of which 7 had mild hearing loss, 14 moderate, 17 severe, and 9 profound. The median MoCA score was 23 (18-26), 19.5 (15-25), 20 (16-23), and 21 (13-22) in patients with mild, moderate, severe, and profound hearing loss, respectively (p = 0.192). The Phototest score was 40 (38-49), 38.5 (27-43), 41 (34-43), and 37(32-38) in patients with mild, moderate, severe, and profound hearing loss, respectively (p = 0.475). The overall prevalence of cognitive impairment among patients with hearing loss was of 83%, and dementia syndrome of 6.4%. CONCLUSIONS: The prevalence of cognitive impairment was high among patients with hearing loss and higher than that reported in the literature. Meanwhile, dementia was less frequent than in other reports. [ABSTRACT FROM AUTHOR]

Introduction: Alzheimer's disease represents a serious public health problem that tends to worsen over time. Among the most important genetic predisposing factors is the presence of the ε4 allele of the apoprotein E gene (APOE). Objective: To determine the allelic and genotypic frequencies of the APOE isoforms in adults over 60 years old with mild cognitive impairment and Alzheimer's disease in Gran Caracas and in the indigenous Pemón community of the Kamarata-Kanaimö area, Bolívar State. Materials and methods: We studied 267 patients: 96 controls, 40 with mild cognitive impairment, 108 with Alzheimer's from Caracas, and 23 individuals from Kamarata-Kanaimö. The APOE isoforms were determined with the AP1210Z: Seeplex® ApoE Genotyping kit. Results: The allele ε4 showed a significant association with mild cognitive impairment (OR=5.03; 95% CI: 0.98-25.70) and EA (OR=5.78; 95% CI: 1.24-26.85). The genotype frequencies for the control and mild cognitive impairment groups were ε3/ε3> ε3/ε4> ε2/ε4> ε3/ε2> ε4/ε4, and for the Alzheimer's group, ε3/ε3> ε3/ε4> ε4/ε4> ε2/ε4> ε3/ε2 In Kamarata-Kanaimö, the order was ε3/ε3> ε3/ε4> ε4/ε4; the allele ε2 was not found in this group. Conclusions: APOE allelic and genotypic frequencies in our sample showed a similar distribution to those found in other studies in Venezuela and the Americas. The absence of the ε2 allele in the indigenous community of Kamarata-Kanaimö warrants further investigation. The positive association of the ε4 allele with both Alzheimer's and mild cognitive impairment was reinforced. The early determination of the ε4 allele carriers can help establish preventive measures in our population. [ABSTRACT FROM AUTHOR]

Copyright of Salud Uninorte is the property of Fundacion Universidad del Norte and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Biomédica: Revista del Instituto Nacional de Salud is the property of Instituto Nacional de Salud of Colombia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: to analyze the definitions used in clinical studies to measure delayed neurocognitive recovery (dNCR) and postoperative neurocognitive disorder (pNCD). Methods: an exploratory review of the literature. Clinical studies on postoperative neurocognitive disorder published since 2013 in journals indexed in Pubmed or Scopus were included. We critically analyzed the methods for assessing dNCR and pNCD, considering as reference the consensus's recommendations. Results: we identified 13 studies, four randomized clinical trials, and nine observational studies. Only three of these studies used definitions consistent with the consensus for dNCR or pNCD. The main reasons for non-adherence were the measurement points and the non-exclusion of delirium and other mental disorders as potential cognitive decline causes. Conclusion: despite assuming the nomenclature of perioperative neurocognitive disorders, the studies failed to adhere to the diagnostic criteria and measurement points. We propose developing a Core Outcome Set as a strategy to advance to perform more homogeneous, high-quality, and relevant evidence for clinical decision making. [ABSTRACT FROM AUTHOR]

The objective of this investigation was to explore the neuropsychological characteristics of institutionalized healthy Cuban older adults. Quantitative research was developed, with a descriptive cross-sectional design through surveys, between March and April 2021. The instruments used were Trail Making Test, Verbal Fluency Test, Modified Wisconsin Letters Test, Boston Denomination Test, Cognitive Reserve Scale, Barthel Index, Lawton and Brody Scale, IDARE, and the Geriatric Depression Scale. The sampling was non-probabilistic and intentional. The sample consisted of 21 participants. The data were processed using SPSS / Windows-25, through descriptive statistics and correlational analysis. Deficits were found in attentional and executive control, verbal fluency, and in inhibitory control and mental flexibility. Moderate levels of anxiety and absence of clinical signs of depression were found. Most of the participants were functionally independent. Significant correlations were found between the variables: depression and inhibitory control; cognitive reserve and age; cognitive reserve and verbal fluency; inhibitory control, mental flexibility, and language skills; age, years of schooling, level of education and verbal fluency. The deficits found suggest that the changes presented by the participants no longer belong to the set of manifestations of normal aging. [ABSTRACT FROM AUTHOR]

Copyright of Revista Salud UIS is the property of Universidad Industrial de Santander and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Salud, Ciencia y Tecnología is the property of Fundacion Salud, Ciencia y Tecnologia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Background: The need for neurocognitive intervention in older adults, as well as the various positions regarding its benefits, justify the relevance of systematizing the dissimilar proposals for neurocognitive intervention in people with and without cognitive deficits. Knowledge of the impact of these interventions on the cognitive health of these people is vitally important. Objective: to describe, through a systematic review of the scientific literature, the effects of neurocognitive intervention on cognitive health in healthy older adults, and in older adults with mild cognitive impairment or dementia. Methods: a descriptive study was carried out, which consisted of a systematic review of the scientific literature on the subject; and started from the search in the databases: PubMed, PsycInfo, Scielo, Cochrane and EBSCO, from August to December 2018. The PRISMA Declaration was used. 426 articles were found. After applying the inclusion, exclusion and exit criteria, and analyzing the overlap effect, six articles made up the sample. Results: the main forms of neurocognitive intervention were stimulation and training. The most frequently used modality was neurocognitive stimulation. Effects of improvement in processing speed, selective attention, planning, reaction time, categorization, verbal fluency, comprehension, visual recognition and orientation were reported. Conclusion: The existing empirical evidence on the implementation of neurocognitive intervention programs during the last ten years points to paths towards effective intervention and improvement of the quality of life of adults. [ABSTRACT FROM AUTHOR]

Copyright of Revista Ciencias de la Salud is the property of Colegio Mayor de Nuestra Senora del Rosario and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Gerokomos is the property of Indemm Farma SL and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Dilemas Contemporáneos: Educación, Política y Valores is the property of Dilemas Contemporaneos: Educacion, Politica y Valores and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Introduction: Parkinson's disease (PD) is a chronic progressive neurodegenerative disorder. The presence of cognitive impairment is one of the non-motor symptoms that a patient with Parkinson's disease may present; it is very important because it affects, in particular, executive, attentional, visuospatial and memory domains. Objective: to determine the relationship between the presence of cognitive impairment and the clinical characteristics of patients with Parkinson's disease belonging to the Municipality of Cifuentes. Methods: a descriptive, cross-sectional, observational study was carried out in the health areas of Cifuentes from October 2013 to October 2019. The study population consisted of 34 patients, the population coincides with the study sample. Results: 76.47% of the study patients presented cognitive impairment compared to 64.70% of the patients who were found to be cognitively impaired (according to the clock drawing test). A trend is observed, both with the Movement Disorder Society-Unified Parkinson's Disease Rating Scale and with the Hoehn and Yarh scale, that the greater the degree of severity, the greater the prevalence of cognitive impairment. Conclusions: patients between 61 and 70 years of age and male sex have a higher risk of developing Parkinson's disease. According to the clock drawing test and the minimental state examination, patients with Parkinson's disease with cognitive impairment predominated. There was a tendency that the higher the degree of severity, the higher the prevalence of cognitive impairment. [ABSTRACT FROM AUTHOR]

Copyright of Gerokomos is the property of Indemm Farma SL and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: To assess the prevalence of goiter and iodine deficiency in indigenous pregnant women coming from five non-metropolitan areas in Colombia. Materials and methods: Descriptive cross-sectional cohort study that included pregnant women of any gestational age with no pregnancy-related conditions, seen in community health centers or in their homes. Patients with comorbidities at the time of pregnancy and those who were receiving iodine supplementation were excluded. Simple random sampling was used. The sociodemographic and obstetric characteristics, urinary iodine concentration and the presence of goiter were measured in accordance with the World Health Organization methodology. A descriptive analysis was performed. Results: Of 189 indigenous pregnant women who were candidates to enter the study, 2 declined participation, and 62 had exclusion criteria, and 125 were included in the final analysis. The mean urinary iodine concentration was 184.4 μg/L (minmax: 12.0-390.0). A total of 42 women (33.6%) had iodine deficiency (< 100 μg/L), and goiter (grade 1-2) was found in 43 (34.4%). No grade 3 or 4 goiter was identified. Conclusions: A high prevalence of goiter and iodine deficiency was found in indigenous pregnant women living in non-metropolitan areas. There is a need to assess maternal and perinatal effects and to implement nutritional interventions. [ABSTRACT FROM AUTHOR]

Introduction. Within the aging process, most organic systems maintain their basal functions. However, there is a reduction in functional reserve and the capacity to compensate physiological stress, which makes older patients more prone to postoperative complications. A study was performed in institutions in Bucaramanga to determine the incidence of postoperative cognitive dysfunction and the associated risk factors. Methodology. This was a analytical observational prospective cohort study performed in healthcare institutions inBucaramanga in 2017 with patients older than 55 years of age under regional, balanced general or total intravenous anesthesia. Results. One hundred and seventy-three operated patients were studied, among which 112 (64.74%) were women and 61 (35.26%) were men. The most commonly used anesthetic techniques were: regional (46.24%) and balanced general (44.51%). Short-term Postoperative Cognitive Dysfunction incidence was 6.36% in previously healthy patients, with an adjusted significant P value (0.001). Cognitive deterioration was detected in 51.41% of patients, with alterations in their mastery of language, attention and memory. This increased for the long-term evaluation. During long-term patient follow-up, it resulted in 11.55%, determining the incidence of delayed Postoperative Cognitive Dysfunction at 17.91%. The anesthetic technique with the highest proportion of longterm dysfunction was mixed anesthesia, compared to regional anesthesia. Discussion. There is currently no standardized definition for Postoperative Cognitive Dysfunction. It has been observed more frequently and for longer extensions in older patients. The study demonstrated a significantly lower early incidence when compared to international articles, but a greater incidence of delayed postoperative dysfunction as a result of more intraoperative complications compared to other studies. Conclusions. Postoperative Cognitive Dysfunction involves multiple risk factors. The study observed a greater association with age, level of education, hypotension and general anesthesia. There was no association between comorbidities and Postoperative Cognitive Dysfunction. The presence of hypotension was determined for developing this dysfunction. [ABSTRACT FROM AUTHOR]

Copyright of Revista de la Asociación Odontológica Argentina is the property of Asociacion Odontologica Argentina and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: To identify risk factors for depression after and ischemic ictus (DII) in adults. Methods: A non-matched case-control study was carried-out including 81 cases and controls, respectively recruited from the neurologic outpatient clinic of Hospital Santa Rosa de Lima from September to December of 2018. Clinical and epidemiological data were gathered and stored in a data base. The Hamilton Depression Rating Scale was used to diagnose depression. Odds rations and 95% CI were calculated and a multivariate logistic regression analysis was used. Results: smoking (OR=4.67; IC95%, 1.99-10.92, p<0.001), lesion located on the left hemisphere (OR=3.11; IC95%, 1.41-6.84, p=0.005) and cognitive deterioration (OR=3.18; IC95%, 1.42-7.10, p=0.005) were independently associated with DII. Conclusions: Smoking, lesions located on the left hemisphere and cognitive deterioration were associated with DII but further studies are needed to elucidate the nature of these associations. [ABSTRACT FROM AUTHOR]

Foundation: cerebrovascular disease occupies the third place as a cause of death to be overcome only by cardiovascular diseases and cancer. It constitutes the first cause of permanent disability in the adult and the second of dementia. Objective: to characterize patients with cerebrovascular disease and cognitive disorder. Methods: an observational, descriptive, cross-sectional study, carried out in the Neurology Service of the Gustavo Aldereguía Lima Hospital in Cienfuegos, which included 27 patients hospitalized in this center, with cognitive impairment, after the first event of ischemic cerebrovascular disease. The variables were analyzed: sex, age, skin color, schooling, occupation, marital status, origin, toxic habits, personal pathological history, type of cerebrovascular disease, affected brain structure, cognitive impairment (using the minimum Folstein mental state test and the Montreal cognitive assessment test), neuropsychological alterations, depression (using the Yessavage geriatric depression scale). Results: Elderly adults, male sex and white skin color predominated, as well as low level of schooling and singles. The atherothrombotic ischemic event was the most common and the right hemisphere the most affected. There was cognitive impairment in all patients. The risk factors mostly associated with the disease were high blood pressure, diabetes mellitus and smoking. The majority of patients did not suffer depression after cerebral infarction. Conclusions: older, single adults are more likely to suffer strokes. The low educational level may be a factor associated to cognitive impairment after this disease, but depression that does not always manifests deeply. [ABSTRACT FROM AUTHOR]

Aim: to establish and to analyze a possible relationship between nutritional status, sleep pattern and quality of life in a sample of patients with cognitive dysfunction. Participants and method: an observational, descriptive study of a group of cases with a sample constituted of 48 elderly individuals (aged 65 or over) who agreed to participate in the study and lived in Valencia (Spain). EuroQol (EQ-5D), Oviedo Sleep Questionnaire (OSQ), Mini Mental State de Folsteisn (MMSE) and Mini Nutritional Assessment (MNA) were used in evaluating each individual's case. The association of variables was assessed by correlation between all three variables. Finally, to check the role and predictive capacity of two variables together, a regression model with nutritional status as the dependent variable, sleep pattern as an independent variable and HRQOL as a mediating or suppressing variable was calculated (values of p < 0.05 were considered significant). Results: the average profile of the subjects was that of an 81.5 ± 7.6 year-old widowed woman, with primary education, with 2.40 ± 1.09 children and diagnosed with Alzheimer's disease as principal dementia in 16.7% of the cases. The score of nutritional status (MNA) was 29.95 ± 5.74, for sleep/rest a score of 17.53 ± 11.13 was obtained and for the VAS of the Euro-Qol, 73.70 ± 26.95. Statistically significant Pearson correlations were obtained between the different variables (p < 0.01). Linear regression analysis was applied, with the nutritional status as dependent variable, in relation to the OSQ and the VAS of the Euro-Qol as predictors (independent variables): MNA p < 0.000, OSQ p < 0.014 and VAS p < 0.006. Conclusion: the OSQ score and the VAS score of EQ-5D questionnaire can be considered as independent variables to establish a predictive model for the MNA score (nomogram). [ABSTRACT FROM AUTHOR]

Copyright of Gerokomos is the property of Indemm Farma SL and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Adicciones is the property of Sociedad Cientifica Espanola de Estudios sobre el Alcohol and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Introduction: Antioxidant-rich diet patterns could contribute to the prevention and treatment of early stages of dementia. Nuts have an appreciable antioxidant load and there is evidence of their positive effects on several chronic diseases incidence and death rates. Moreover, they are rich in polyunsaturated fatty acids, which might also play a positive role in neurogenesis. The aim of this systematic review was to summarize the evidence from studies related to the effects of nut consumption on cognitive function among adults. We conducted a systematic search of articles published in PubMed, Scopus and Web of Science. A total of 19 articles met the inclusion criteria (seven cross-sectional, four prospective cohorts and eight experimental); these were independently extracted and reviewed by two reviewers. The evidence from the cross-sectional and cohort studies was uncertain, due to the disparity of results and risk of bias. However, in most experimental studies a protective effect of nut consumption on some dimension of cognitive function was observed and the methodological quality of these studies was acceptable. In addition, the effects appear to be independent of nut type, amount of intake, age and baseline status of subjects. In summary, these results suggest that the inclusion of daily nut consumption in the healthy diet pattern of adults could have positive effects on their cognitive function. Nevertheless, more well-designed longitudinal and experimental studies are needed to provide strength to this suggestive evidence. [ABSTRACT FROM AUTHOR]

Copyright of Acta Médica Peruana is the property of Colegio Medico del Peru and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Introduction: Aim: to establish and to analyze a possible relationship between nutritional status, sleep pattern and quality of life in a sample of patients with cognitive dysfunction. Participants and method: an observational, descriptive study of a group of cases with a sample constituted of 48 elderly individuals (aged 65 or over) who agreed to participate in the study and lived in Valencia (Spain). EuroQol (EQ-5D), Oviedo Sleep Questionnaire (OSQ), Mini Mental State de Folsteisn (MMSE) and Mini Nutritional Assessment (MNA) were used in evaluating each individual's case. The association of variables was assessed by correlation between all three variables. Finally, to check the role and predictive capacity of two variables together, a regression model with nutritional status as the dependent variable, sleep pattern as an independent variable and HRQOL as a mediating or suppressing variable was calculated (values of p < 0.05 were considered significant). Results: the average profile of the subjects was that of an 81.5 ± 7.6 year-old widowed woman, with primary education, with 2.40 ± 1.09 children and diagnosed with Alzheimer's disease as principal dementia in 16.7% of the cases. The score of nutritional status (MNA) was 29.95 ± 5.74, for sleep/rest a score of 17.53 ± 11.13 was obtained and for the VAS of the Euro-Qol, 73.70 ± 26.95. Statistically significant Pearson correlations were obtained between the different variables (p < 0.01). Linear regression analysis was applied, with the nutritional status as dependent variable, in relation to the OSQ and the VAS of the Euro-Qol as predictors (independent variables): MNA p < 0.000, OSQ p < 0.014 and VAS p < 0.006. Conclusion: the OSQ score and the VAS score of EQ-5D questionnaire can be considered as independent variables to establish a predictive model for the MNA score (nomogram). [ABSTRACT FROM AUTHOR]

Introduction: Cognitive Dysfunction (CD) is a disease that increases with age. It is important to know the protective and risk factors for this disease. Methodology: Observational study carried out on 729 people over 65 years of age in community 13 pharmacies for two years. Demographic data were collected (sex, age, level of studies) and lifestyles (love of reading, hobbies such as crossword puzzles or sudokus etc, TV hours), and the SPMSQ (Short-Portable Mental State Questionaire) test of Pfeiffer and Mini- Mental State Examination (MMSE) were carried out to check the patient's CD. A bibliographic review of the subject was also conducted. Results: 17.6% of CD was detected. A statistically significant association was found as a protection against CD with a love of reading and the level of studies. No association was found with TV hours or hobbies. The literature review provided more protective and risk factors. Discussion: With our data we can affirm that both cognitive reserve (years of study) and cognitive stimulation (hours of reading) protect from CD. No coincidences were found on the other data obtained, so it would be necessary to increase the sample size in order to make a more effective comparison. Conclusions: Low educational level is a risk factor for CD while higher education would be a preventive factor. Reading is a protective factor of CD. [ABSTRACT FROM AUTHOR]

Copyright of Médicas UIS is the property of Universidad Industrial de Santander and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Introduction: Late CNS complications secondary to radiotherapy are more frequently seen, affecting significantly the patients' quality of life. There is no approved pharmacological treatment for this type of late cognitive decline. Case report: We evaluated clinically a patient with late cognitive decline attributed to radiotherapy. A trial with memantine showed benefits on his cognitive performance. A statistical analysis was in use type goodness of fit with statistics chi square, to evaluate the impact of the medicament in this case with cognitive late dysfunction. There was obtained a beneficial not attributable result at random. Conclusions: Memantine could be useful in the treatment of late cognitive decline due to radiotherapy. However, it is necessary information derived from clinical trials to conclude that memantine is effective in tardive dementia associated with radiotherapy. [ABSTRACT FROM AUTHOR]